RSS

CURE Pharmaceutical

CURE Pharmaceutical, a disruptive drug delivery technology and pharmaceutical cannabinoid molecule company, has formed a partnership with a pharmaceutical distribution company to deliver a generic ED drug into the Asian market. Read more

News

CURE Pharmaceuticals, developer of drug delivery technology and pharmaceutical cannabinoid molecules, has signed a memorandum of understanding (MOU), entering into a research collaboration with two Israeli companies. Read more

News

Disruptive drug delivery technology and pharmaceutical cannabinoid molecule development company, CURE Pharmaceutical, expects increased demand for its transdermal drug delivery platform Read more

News